The quality of safety reporting in trials is still suboptimal: Survey of major general medical journals
Authors:
- Anna-Bettina HaidichAHAnna-Bettina Haidich
- Charis BirtsouCBCharis Birtsou
- Theodore DardavessisTDTheodore Dardavessis
- Ilias TirodimosITIlias Tirodimos
- Malamatenia ArvanitidouMAMalamatenia Arvanitidou
- 1 February 2011
- journal article
- review article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 64 (2) , 124-135
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT StatementAnnals of Internal Medicine, 2004
- The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklistControlled Clinical Trials, 2002
- Improving Safety Reporting from Randomised TrialsDrug Safety, 2002
- Reporting drug safety in clinical trials: getting the emphasis rightThe Lancet, 2001
- Use of the CONSORT Statement and Quality of Reports of Randomized TrialsJAMA, 2001
- Value of Flow Diagrams in Reports of Randomized Controlled TrialsJAMA, 2001
- The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and ElaborationAnnals of Internal Medicine, 2001
- Completeness of Safety Reporting in Randomized TrialsJAMA, 2001
- Reporting of safety data from randomised trialsThe Lancet, 1998
- Improving the quality of reporting of randomized controlled trials. The CONSORT statementJAMA, 1996